key: cord-0687275-xhsquecy authors: Kuroda, Naoto title: What should we ask the patients with epilepsy on telemedicine during COVID-19 crisis? A checklist for the clinicians date: 2020-05-25 journal: Epilepsy Behav DOI: 10.1016/j.yebeh.2020.107184 sha: 837837ef328dae2cb24c9bf9c37b98e6f8e15ebd doc_id: 687275 cord_uid: xhsquecy • Telemedicine is recommended as an option for outpatients due to the COVID-19. • Epileptologists are required to immediately change their practice to telemedicine. • We have developed an eight-point telemedicine checklist for epilepsy care. Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak initially occurred in Wuhan, China in late 2019 and is spreading globally [1] . Every society has had to adapt to changes induced by the COVID-19 crisis. Epilepsy is a chronic neurological disorder characterized by the spontaneous recurrence of unprovoked seizures. In the field of neurology, as well as other areas of medicine, telemedicine is recommended as an alternative to outpatient practice during the COVID-19 crisis to avoid the risk of exposure to SARS-CoV-2 [2] . Every clinician is attempting to change their practice style due to this worldwide crisis. Here, we provide suggestions as well as a checklist for clinicians to introduce telemedicine during this crisis (Fig. 1 ). Clinical characteristics of coronavirus disease 2019 in China The coronavirus disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders Drug-resistant epilepsy Malnutrition and epilepsy: a two-way relationship New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study Epilepsy field workers, a smartphone application and telephone telemedicine: safe and effective epilepsy care in rural Nepal The Epilepsy Foundation New England. Coronavirus information for people affected by epilepsy in New England Ketogenic diet for epilepsy treatment Recommendations for deep brain stimulation device management during a pandemic Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention Covid-19: risk factors for severe disease and death Neonatal seizure models to study epileptogenesis Dravet syndrome: a review of current management Latest coronavirus guidance for children and adults with Dravet syndrome Influence of stress associated with chronic alcohol exposure on drinking Severe psychological distress among epilepsy patients during the COVID-19 outbreak in southwest China Antiepileptic drug effects on mood and behavior: molecular targets How might COVID-19 affect me if I have epilepsy? Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study Providing contraception for young people during a pandemic is essential health care How to fight an infodemic